Patents for A61P - Specific therapeutic activity of chemical compounds or medicinal preparations (3,181) |
---|
04/24/2008 | US20080097117 chemical intermediates for making antiinflammatory agents treating autoimmune disease; 1-[2-(Fluoren-3-yl)ethyl]-(4-(3-trifluoromethylphenyl)-1,2,3,6-tetrahydropyridine drug |
04/24/2008 | US20080095788 Vaccines |
04/23/2008 | CN100383141C Pyrazolo [4,3-d] pyrimidine derivatives |
04/16/2008 | EP1165549B1 C7 carbamoyloxy substituted taxanes as antitumor agents |
04/09/2008 | CN101156861A Combretastatin a-4 phosphate prodrug salts with nitrogen-containing compounds |
04/09/2008 | CN100379743C New oxabispidine compound useful in treatment of cardiac arrhythmias |
04/09/2008 | CN100379739C Process for preparing azacycloalkanoylaminothiazoles |
04/09/2008 | CN100379433C Method of treating diabetes by using plant argyrolobium roseum extract |
04/03/2008 | US20080081050 Vaccine against streptococcus pneumoniae |
04/02/2008 | EP1905449A2 Vaccines |
04/02/2008 | CN100378100C Pyrazolo(4,3-d)pyrimidine derivatives |
04/02/2008 | CN100378074C 2-,3-4- or 5-substituted-n1-(benzensulfonyl)indoles and their use in therapy |
04/01/2008 | US7351858 Ortho-substituted benzoic acid derivatives for the treatment of insulin resistance |
04/01/2008 | US7351821 Oxabispidine compounds useful in the treatment of cardiac arrhythmias |
04/01/2008 | CA2432578C Quinazolone derivatives as alpha 1a/b adrenergic receptor antagonists |
03/26/2008 | CN100376567C Qinazoline derivatives as VEGF inhibitors |
03/25/2008 | US7348324 Cyclic amine compounds as CCR5 antagonists |
03/25/2008 | CA2343123C Active substance concentrate with formoterol, suitable for storage |
03/20/2008 | US20080069842 Vaccines for Mycoplasma bovis and methods of use |
03/19/2008 | CN101143898A Treatment of allergic conditions by use of IL-21 |
03/19/2008 | CN100375742C 4-oxoquinoline compounds and its use |
03/18/2008 | US7345094 Synergistic; side effect reduction; melanomas; toxicity; 2,5-Dimethoxythiobenzoic Acid N-methylhydrazine; anticancer |
03/18/2008 | US7345050 Imidazo(1,2a)pyridine or pyrazolo(2,3a)pyridine derivatives; Alzheimer's and Parkinson's Disease; nervous system, brain, and psychological disorders |
03/18/2008 | CA2355776C Phospholipid complexes of proanthocyanidin a2 as antiatherosclerotic agents |
03/12/2008 | EP1897546A1 Combined compositions comprising (e)-7-[4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]pyrimidin-5-yl](3r,5s)-3,5-dihydroxyhept-6-enoic acid |
03/11/2008 | US7342019 5, 6-diaryl-pyrazine-2-amide derivatives as CB1 antagonists |
03/06/2008 | US20080058297 Heterocyclic Compounds For Preventing And Treating Disorders Associated With Excessive Bone Loss |
03/05/2008 | CN101137388A Anti-adhesion composites and methods os use thereof |
03/05/2008 | CN100372845C Polycyclic compounds as potent alpha2-adrenoceptor antagonists |
02/27/2008 | EP1268470B1 Dual molecules containing a peroxide derivative, synthesis and therapeutic applications thereof |
02/27/2008 | EP1163000B1 Vaccine against antigens from bacteriae |
02/27/2008 | CN101130071A Vaccine |
02/27/2008 | CN100371323C Cyanopyrrolidine derivatives |
02/27/2008 | CN100370987C Tartrate salt of 5,8,14-triazatetracyclo [10,3,1,02,11.04,9]-hexzdeca-2(11),3,5,7,9-pentaene |
02/20/2008 | CN101125864A Heteroaromatic inhibitor for fructose-1,6-bisphosphatase |
02/20/2008 | CN100369898C Nicotinamide derivates useful as p38 inhibitors |
02/14/2008 | US20080039373 Pegylated Factor VII Glycoforms |
02/13/2008 | EP1886994A1 Cyclic amine compounds as CCR5 antagonists |
02/13/2008 | EP1572220B1 Antiviral properties of extracts of dichrostachys glomerata |
02/13/2008 | EP1517679B1 Ortho-substituted benzoic acid derivatives for the treatment of insulin resistance |
02/13/2008 | CN100367965C Use of bioactive metabolites of gepirone for the treatment of psychological disorders |
02/05/2008 | US7326723 Autoimmune disease; antiinflammatory agents |
02/05/2008 | US7326722 N-[Phenyl(piperidin-2-yl)methyl]benzamide derivatives, their preparation and their application in therapy |
01/23/2008 | EP1880735A2 Vaccine |
01/17/2008 | US20080015215 Diamine derivatives |
01/17/2008 | US20080015206 Anti-cancer cyclopenta[G]quinazoline compounds |
01/16/2008 | EP1878720A1 Process for preparing chiral bicycloprolinates as intermediates for the preparation of peptidomimetic protease inhibitors |
01/16/2008 | EP1429754B1 Combination of selected opioids with muscarine antagonists for treating urinary incontinence |
01/16/2008 | CN100362010C Mevalonic acid derivative |
01/09/2008 | EP1876173A1 Chiral intermediates for the preparation of peptidomimetic protease inhibitors |
01/09/2008 | CN101099865A A blocking monoclonal antibody to VLA-1 and its use for the treatment of vascular disorders |
01/09/2008 | CN101099745A Methods and compositions for treating flaviviruses and pestiviruses |
01/08/2008 | CA2296031C Novel spiroazabicyclic heterocyclic compounds |
01/02/2008 | EP1124828B1 Pyrano, piperidino, and thiopyrano compounds and methods of use |
01/02/2008 | CN101098669A Component for forming a seal around an opening in the skin |
01/02/2008 | CN101096337A Aralkyl-tetrahydro-pyridines, their preparation and pharmaceutical compositions containing same |
12/26/2007 | CN100356978C Novel exendin agonist formulations and methods administration thereof |
12/20/2007 | US20070293527 1-Methyl-1,3,4,5,6,11b-hexahydro-2H-11-oxa-4a-aza-benzo[a]fluoren-1-ol; alpha 2C adrergic receptors; adrenergic blocking agents; central nervous system; cognition activators; antidepressants; anxiolytic agents; peripheral nervous syster; antidiabetic agents; hypertensive agents; Raynaud's disease |
12/20/2007 | US20070292513 Pazopanib hydrochloride and synthesis, chemical intermediates, and dosage forms thereof; anticancer; colon cancer, breast cancer |
12/19/2007 | CN100355755C Diazabicyclic central nervous system active agents |
12/18/2007 | CA2418479C Prodrugs of betulinic acid derivatives for the treatment of cancer |
12/12/2007 | EP1864975A2 Novel compounds |
12/11/2007 | US7307090 Piperidine derivatives useful as modulators of chemokine receptor activity |
12/05/2007 | EP1862457A2 Fluoropyrrolidines as dipeptidyl peptidase inhibitors |
12/05/2007 | EP1656183B1 Treatment of male sexual dysfunction |
12/05/2007 | EP1137642B1 Bis-sulfonamides |
12/05/2007 | CN101081869A Humanized antibodies that recognize beta amyloid peptide |
12/05/2007 | CN101081868A Humanized antibodies that recognize beta amyloid peptide |
12/05/2007 | CN101081867A Humanized antibodies that recognize beta amyloid peptide |
12/04/2007 | US7304083 2-iminoimidazole derivatives (2) |
11/28/2007 | EP1448201B1 N-(indolcarbonyl-)piperazine derivatives for the treatment of obesity |
11/28/2007 | CN100351253C Pyrrolo [2,3-d] pyrimidine compounds as immunosuppressive agents |
11/28/2007 | CN100350919C Dietary or pharmaceutical composition for use for the prevention or treatment of hyperoxaluria |
11/27/2007 | US7301023 Immunosuppressants; grafting of organs; rheumatic diseases |
11/22/2007 | US20070270427 vascular endothelial growth factor receptor inhibitors such as N2-(3-methyl-1H-indazol-6-yl)-N4-{3-[(methylsulfonyl)methyl]phenyl}-1,3,5-triazine-2,4-diamine trifluoroacetate, used as anticarcinogenic, antitumor or antiproliferative agents |
11/21/2007 | CN100349904C Novel heteroaromatic inhibitors of fructose 1,6-bisphosphatase |
11/20/2007 | US7297701 Anti-cancer cyclopenta [G]quinazoline compounds |
11/20/2007 | US7297692 1,3-dihydro-2H-indol-2-one derivatives, process for preparing them and pharmaceutical compositions containing them |
11/20/2007 | US7297353 For oral administration, injection and topical application; can eliminate the aseptic inflammations, edema, adhesion caused by aseptic inflammations, and stubborn pain, complex body disorders caused by aseptic inflammation, edema and adhesion |
11/20/2007 | CA2300289C A pharmaceutical composition active in reducing production of mcp-1 protein |
11/15/2007 | US20070265286 Quinazoline derivatives as VEGF inhibitors |
11/15/2007 | US20070265282 Use of ticagrelor treating myocardial infarction, thrombotic stroke, angina and transient ischemic attacks |
11/15/2007 | US20070264333 Method of treatment |
11/14/2007 | CN100348580C Taxol enhancer compounds |
11/08/2007 | US20070259944 Amides such as 5-(3-Nitrophenyl)-1,3-dihydro-indol-2-one, used as antiprogesterones, contraceptives, for hormone replacement therapy during menopause and as anticarcinogenic agents |
11/07/2007 | CN101066952A Crystalline pharmaceutical |
11/06/2007 | US7291732 Isomeric fused pyrrolocarbazoles and isoindolones |
11/01/2007 | WO2005000402A3 Anti-adhesion composites and methods os use thereof |
10/31/2007 | EP1849797A2 Peptidomimetic protease inhibitors |
10/31/2007 | CN101062415A Use of IL-18 inhibitors |
10/31/2007 | CN101062056A Low concentration of peroxide for treating or preventing vaginal infection |
10/31/2007 | CN101062037A Thioxanthine derivatives, process for their preparation (variants), their use and composition containing them |
10/31/2007 | CN100345844C Quinazoline derivatives for the treatment of tumours |
10/25/2007 | US20070248614 Vaccination |
10/17/2007 | EP1474395B1 Nicotinamide derivates useful as p38 inhibitors |
10/17/2007 | EP1204649B1 Arylmethyl-carbonylamino-thiazole derivatives and their use as antitumor agents |
10/17/2007 | CN100343252C Novel imidazopyridine compounds with therapeutic effect |
10/16/2007 | US7282518 Benzimidazole compounds for modulating IgE and inhibiting cellular proliferation |
10/11/2007 | US20070238759 Novel Polymorph V of Torasemide |
10/10/2007 | EP1319007B9 Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function |